MACUS T KUO to Liver Neoplasms
This is a "connection" page, showing publications MACUS T KUO has written about Liver Neoplasms.
Connection Strength
0.253
-
Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers. Mol Carcinog. 2006 Sep; 45(9):701-9.
Score: 0.043
-
Identification and characterization of a hepatoma cell-specific enhancer in the mouse multidrug resistance mdr1b promoter. J Biol Chem. 1995 Oct 27; 270(43):25468-74.
Score: 0.041
-
Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study. Ann Surg Oncol. 1994 Sep; 1(5):389-99.
Score: 0.038
-
Expression of multidrug-resistance (P-glycoprotein) genes in liver cancers: a molecular example of the convergence theory of hepatocarcinogenesis? Mol Carcinog. 1993; 7(2):73-5.
Score: 0.033
-
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. Br J Cancer. 2012 Apr 24; 106(9):1481-5.
Score: 0.032
-
Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice. Int J Cancer. 2002 Jan 01; 97(1):52-7.
Score: 0.031
-
Prolonged stability and sustained prodrug cell killing activity using receptor-mediated delivery of malarial circumsporozoite-cytosine deaminase fusion protein into liver cancer cells. Mol Cancer Ther. 2002 May; 1(7):461-7.
Score: 0.016
-
Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP-1 binding site. DNA Cell Biol. 1991 Nov; 10(9):639-49.
Score: 0.008
-
Arginine deprivation as a targeted therapy for cancer. Curr Pharm Des. 2008; 14(11):1049-57.
Score: 0.006
-
Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. J Exp Ther Oncol. 2007; 6(4):335-48.
Score: 0.006